Kayne Anderson Rudnick Investment Management LLC trimmed its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 9.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,013,777 shares of the company's stock after selling 103,418 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned 6.71% of U.S. Physical Therapy worth $89,932,000 as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of USPH. CBIZ Investment Advisory Services LLC boosted its position in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after acquiring an additional 122 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares in the last quarter. Pacer Advisors Inc. bought a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at approximately $113,000. Mutual of America Capital Management LLC bought a new position in U.S. Physical Therapy in the fourth quarter worth $203,000. Finally, KLP Kapitalforvaltning AS bought a new position in U.S. Physical Therapy in the fourth quarter worth $257,000.
Wall Street Analysts Forecast Growth
USPH has been the topic of a number of recent research reports. StockNews.com downgraded shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research report on Thursday. Barrington Research decreased their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. JPMorgan Chase & Co. dropped their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 19th. Finally, William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $109.00.
Get Our Latest Research Report on USPH
U.S. Physical Therapy Trading Down 1.7 %
Shares of NYSE USPH opened at $67.28 on Friday. The firm's 50 day moving average price is $76.43 and its 200-day moving average price is $84.79. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $108.14. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The company has a market cap of $1.02 billion, a PE ratio of 71.57, a P/E/G ratio of 3.54 and a beta of 1.38.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.
U.S. Physical Therapy Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 14th were paid a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.80 annualized dividend and a yield of 2.68%. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. U.S. Physical Therapy's dividend payout ratio is currently 97.83%.
Insider Activity
In related news, COO Graham D. Reeve sold 1,730 shares of the firm's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.70% of the company's stock.
U.S. Physical Therapy Company Profile
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.